The favorable prognosis associated with continued expression and nuclear localization of Stat5a in invasive breast cancer supports the hypothesis drawn from in vitro studies that, despite a potential role in tumor initiation, Stat5a signaling is important for maintaining tumor differentiation and suppressing disease progression in established human breast cancer [11,12,20,21]. The gene discussed is STAT5A; the disease is breast carcinoma.